MANFRINATO, Maria Cristina
 Distribuzione geografica
Continente #
NA - Nord America 3.659
EU - Europa 1.171
AS - Asia 808
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 6
OC - Oceania 5
SA - Sud America 1
Totale 5.658
Nazione #
US - Stati Uniti d'America 3.649
CN - Cina 470
UA - Ucraina 295
IT - Italia 237
DE - Germania 172
TR - Turchia 143
GB - Regno Unito 134
SG - Singapore 107
PL - Polonia 89
FI - Finlandia 73
SE - Svezia 68
HK - Hong Kong 31
BE - Belgio 20
CZ - Repubblica Ceca 19
FR - Francia 17
NL - Olanda 14
ID - Indonesia 11
IR - Iran 10
VN - Vietnam 9
CA - Canada 8
ES - Italia 7
MY - Malesia 7
RO - Romania 6
SD - Sudan 6
IQ - Iraq 5
KR - Corea 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EU - Europa 4
IE - Irlanda 4
AU - Australia 3
IN - India 3
PT - Portogallo 3
BG - Bulgaria 2
GR - Grecia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BR - Brasile 1
GE - Georgia 1
MK - Macedonia 1
MX - Messico 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
Totale 5.658
Città #
Woodbridge 521
Fairfield 340
Jacksonville 330
Chandler 324
Houston 301
Ann Arbor 281
Ashburn 200
Wilmington 139
Ferrara 118
Cambridge 113
Nanjing 109
Seattle 107
Izmir 99
Beijing 88
Princeton 81
Warsaw 76
Boardman 66
Singapore 61
Dearborn 57
Milan 44
Shanghai 37
Nanchang 36
San Diego 33
Shenyang 32
Hong Kong 30
Changsha 28
Tianjin 24
Los Angeles 22
Brussels 20
Bremen 19
Brno 18
Jiaxing 17
Hebei 16
Orange 15
Addison 14
Ningbo 14
Jinan 13
Norwalk 13
San Mateo 12
New York 11
Redwood City 11
Augusta 10
Mountain View 10
Auburn Hills 9
Dong Ket 9
Helsinki 9
Jakarta 9
Kraków 9
Washington 8
Des Moines 7
Falls Church 7
Leawood 7
Philadelphia 7
Bologna 6
Casalecchio Di Reno 6
London 6
Montréal 6
Munich 6
Guangzhou 5
Indiana 5
Lübeck 5
Tappahannock 5
Wageningen 5
Ardabil 4
Chicago 4
Dronten 4
Dublin 4
Düsseldorf 4
Ferrara di Monte Baldo 4
Fuzhou 4
Haikou 4
Khartoum 4
Rome 4
Shah Alam 4
Taizhou 4
Zhengzhou 4
Calderara Di Reno 3
Changchun 3
Frankfurt am Main 3
Hefei 3
Kunming 3
Paris 3
Taipei 3
Verona 3
Amsterdam 2
Chisinau 2
Dolo 2
Hsinchu 2
Kuala Lumpur 2
Lanzhou 2
Las Vegas 2
Madrid 2
Melbourne 2
Sofia 2
Sulaymaniyah 2
Tehran 2
Acton 1
Albuquerque 1
Alexandria 1
Athens 1
Totale 4.150
Nome #
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 158
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 150
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 147
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 130
null 128
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 125
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 124
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 123
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 112
null 110
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 108
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 106
null 104
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 101
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 98
null 97
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 94
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 91
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 89
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 89
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 88
null 88
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 87
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 86
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 84
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 84
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 83
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 82
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 81
Substrate binding to 6-phosphogluconate dehydrogenase 79
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 79
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 77
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 76
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 75
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 68
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 67
Mutual communication of envelope glycoproteins of paramixoviruses 67
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 67
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 66
Domain structure of the hemagglutinin-neuraminidase from sendai virus 66
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 65
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 65
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 64
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 64
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 64
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 63
Biochemical study in adult population with stroke in Ferrara, Fabry disease 63
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 62
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 62
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 62
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 61
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 61
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 58
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 56
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 56
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 56
Purification of transglutaminase enzyme from L. infantum promastigotes 56
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 55
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 55
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 54
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 54
null 53
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 53
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 51
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 50
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 50
null 49
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 47
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 43
MMP-9 isoforms in serum of Multiple Sclerosis patients 43
The influence of different replacement solutions on neutrophils response 43
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 27
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 26
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 25
Effects of anticoagulants on the activity of gelatinases 20
Effects of anticoagulants on the activity of gelatinases 18
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 17
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 15
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 14
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 10
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 9
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 8
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 6
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 6
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 3
Totale 5.776
Categoria #
all - tutte 25.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020871 0 32 25 139 54 130 103 108 84 120 55 21
2020/2021887 79 79 32 79 45 100 54 93 24 121 139 42
2021/2022639 21 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/202589 49 40 0 0 0 0 0 0 0 0 0 0
Totale 5.776